SSTR2 and neoplasm: In order to augment tumor targetability, we synthesized a novel synthetic peptide against Somatostatin receptor 2 (SSTR2) which is a member of the G protein-coupled receptor (GPCR) superfamily especially overexpressed in brain tumor cells [17, 18].